Taikang Asset Management (Hong Kong) CO LTD Legend Biotech Corp Transaction History

Taikang Asset Management (Hong Kong) CO LTD

$472 Million
Q1 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$25.8 - $32.39 $6.81 Million - $8.55 Million	-263,903 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$27.5 - $39.61 $380,572 - $548,162	-13,839 Reduced 4.98%	263,903 $8.15 Million
Q2 2020 Aug 12, 2020	BUY	$36.1 - $42.56 $10 Million - $11.8 Million	277,742 New	277,742 $11.8 Million

Others Institutions Holding LEGN

# of Institutions

213

Shares Held

63.6M

Call Options Held

1.09M

Put Options Held

525K

Price T Rowe Associates Inc Baltimore, MD

10.9M
Shares

$507 Million
0.08% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.98M
Shares

$277 Million
7.45% of portfolio
Black Rock Inc. New York, NY

5.38M
Shares

$249 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

2.61M
Shares

$121 Million
0.03% of portfolio
Capital World Investors Los Angeles, CA

2.39M
Shares

$110 Million
0.02% of portfolio

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $7.75B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taikang Asset Management (Hong Kong) CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Taikang Asset Management (Hong Kong) CO LTD with notifications on news.

Account